Rodent bioassays normally consist of 1 or 2 control groups and usually 3 treatment groups using ascending dose levels of a test substance in both sexes of a specific strain of laboratory rodent. At termination, the tumour incidences recorded in animals from the treatment groups are compared to those in the study control groups. The biologically and statistically significant differences in the incidences are considered treatment-related. The incidences of several tumour types are known to be strain-and sex-specific (Tables I and 11 ). Examples can be seen in Fischer rats, with high incidences of Leydig cell tumours and leukaemia, and in Sprague-Dawley rats, with a high incidence of pituitary tumours. It is well known that 2 control groups within the same study can occasionally show statistically significant differences, stressing the importance of knowing the range of incidence rather than just percentages. However, caution is required prior to its use because "the range" is often dependent on the sample size and could sometimes be misleading.
Bioassays sometimes reveal greater incidence of a tumour type in 1 or more treated groups in comparison to a study control, while the overall incidence remains low. When lower than expected incidence rates fall in control groups, the use of historical control data is often suggested. Care must be taken to ascertain that "like" is compared to "like." The various factors that could influence the incidence of spontaneous tumours in laboratory rodents are discussed in this article. Several authors have reviewed these factors (1-3, 5 , 10, 13). The term "spontaneous" has been used here to denote lesions occurring in animals treated with no known test substances but possibly exposed to a number of external environmental factors. It is also known that several of the tumour types are influenced by these factors. Table I11 summarizes the main factors that influence the tumour incidence in untreated rodents.
VIRUSES
Many viruses are associated with murine tumours and examples reported include mammary tumour virus, mouse leukaemia virus, polyoma virus, retro virus, and DNA virus. Maintenance of mice in a germ-free status reduced the incidence of mammary tumours when compared to normal status (1) .
STRESS
Many of the procedures involved in routine bioassays result in some degree of stress. Adrenal enlargement, associated with congestion and lymphoid depletion of thymus, spleen, and lymph nodes, are frequently recorded in these studies and are evidence of stress. Handling during the studies for various procedural purposes, sudden changes in husbandry practices or in conditions, diseases, and/or separate sexes housed in close proximity can contribute to stress. Low-stress housing is reported to reduce the incidence of mammary tumours in mice (1).
TEMPERATURE
Effect of ambient temperature on the incidence of tumours is shown by the reported reduction of mammary tumours in mice kept under colder laboratory temperatures of 4145°C (1).
BEDDING
Type of bedding used in the cages has been reported to be responsible for an increased incidence of4.iqet.nnd mammary tumours in mice (I). Presence of certain essential oils or other contaminants (like insecticides) in the wood shavings could act as tumour promoters resulting in the greater incidence of hepatic tumours.
CAGEING DENSITY
Gang housing (2-5 animals per cage) and singleanimal housing are common practices in toxicology laboratories. Male mice housed singly are reported to show an increased incidence of liver tumours in 160 comparison to gang housing (5 per cage). Individually housed female mice were heavier and revealed increased liver tumour rates than gang-housed mice (5) . Gang housing (5 per cage) resulted in fewer numbers of liver, lymphoid, and mammary tumours in mice (1 2). Permanently segregated male rats had a lower incidence of interstitial cell tumours of the testes when compared to males housed intermittently with females (1 3).
ALTITUDE
Laboratories maintained at high altitudes (> 14,000 ft) appear to have reduced the incidence of leukaemia in mice (1) .
DIET
The influence of diet on tumour incidence in rodents is widely studied and is of great interest and importance from the health point of the animals and for the purposes of extrapolative data. Restricted diet compared to unrestricted access (ad libifwit) resulted in reduction of lymphoid, mammary, and hepatic tumours and also in overall tumours in mice (13). Restricted diet resulted in a reduction of pituitary tumours in female rats (8) . Calorie restriction reduced the incidence of several spontaneous and induced tumours in mice (1) . Diet restriction to rats significantly improved survival and reduced benign or malignant tumour burden, particularly pituitary and pancreatic islet cell tumours and other nonneoplastic degenerative lesions (1 1). Rats given access to a high consumption of a high-protein, highcalorie diet showed the highest incidence of ne- (1 1). Corn oil by gavage to male Fischer-344/N rats resulted in increased pancreatic acinar tumours and reduced the rate of mononuclear cell leukaemia (5) compared to untreated control rats. This was associated with increased body weights and greater survival. A high-fat diet (1 3-3 1%) given to mice resulted in a greater incidence of mammary and liver tumours (1, 7, 16) . In general, restriction of diet, calories, or certain specific nutrients clearly produce a slimmer, healthier, and more active rodent that lives longer and has fewer tumours compared to the over-fed, obese, lethargic, hormonally unbalanced monster we have all come to know.
LABORATORY P R A~I C E S Interlaboratory variation (1 5) in the incidence of tumours is well known ( Table IV) . The variation can often be so great t h a t 3 is futile to rely on data obtained from different laboratories. Detailed examination suggested a variety of reasons for this. Housing and husbandry practices vary among laboratories. The lab-to-lab variability of tumour rates (e.g., mammary and pituitory tumours) paralleled interlaboratory variability in body weights (5) . Study protocols vary and, thus, the procedures of tissue samplink some laboratories, for example, take 2 blocks of liver, whereas others sample all lobes and abnormalities, forcing obvious sampling differences. Differences in the amount of tissue examined influence the tumour rates as they correlate closely (9) . Standardised sampling is of vital importance in dealing with small or microscopically detected tum-.offc$ such as tumours of the brain, thyroid, adrenal, and pancreas. (Single Vs multiple sections have a profound impact on these, revealing markedly great- Other examples include pancreatic tumours in rodents and brain tumours in rats. Reference (2). er incidences on multiple sectioning (2) ( Table V) . Standardisation of laboratory techniques concerning tissue sampling is essential to control this variability.
PATHOLOGIST'S FACTOR The pathologist's factor is portrayed as an important issue. Differences in the diagnostic criteria among pathologists; differences in the experiences, qualifications, and training of practising pathologists; and a lack of standardisation of terminologies all contribute to this problem. Currently the problems of diagnostic drifts and nomenclature are less serious issues. Recently, acceptance of standardisation of pathological nomenclature among the users proposed by various scientific and professional bodies and the introduction of peer review procedures have helped to reduce this problem. The proper use of pathology peers to interpret pathology data has helped to minimise the difficulties.
TIME PERIOD
Variation of incidence of tumour types within the same strain and sex and within the same laboratory occur due to the progression of time. Incidence rate of pituitary tumours in female rats increased by 5-fold within a time period of 25 yr in the Alderley Park rat (1 7). Incidence of leukaemia is reported to increase from 40 to 80% in C57 BL mice over a 10-yr period in Glaxo Laboratories, Ware (14) . "Genetic drift" and genetic pool drift have been put forward as a cause for this. Although this could have some influence under certain specific circumstances, changes in other external and environmental factors should be studied in detail. Over a period of 10-25 yr, tissue sampling procedures, pathologist's diagnostic criteria, diet and its constituents, and practices of housing and husbandry could all change considerably. Varied sources of procurement of nutrients by the diet companies will also have strong influence over this. Time-related decreases in survival and increases in body weight and prevelance of a number of tumour types were reported in untreated Fischer-344 rats over an 11yr period among National Cancer Institute-Nation-a1 Toxicology Program (NTP) 2-yr studies (9) . The data were obtained from 1 1 different laboratories in the United States under standardised conditions; one of the reasons put forward for this change is the fact that consistently more tissue samples were examined in recent studies than in early studies and some of the increases disappeared when compared for equivalent tissue sizes (9) . The changes reported indicate that the use of historical control data collected over a long period is of little value due to the marked drift; shown. The studies to be compared must fall within a short window of time to be of any me. It is interesting to point out that, with a large pool of data (several studies per year), if sources of variabilities are recognised and strictly controlled especially within the context of a single laboratory, the drift'in the incidence rates of tumour types over a period are not necessarily so obvious. Results analysed at Huntingdon Research Centre over a period of 9 yr (1979-1987) on certain tumour types show that, although there are fluctuations, incidence rates remained within a small band ( Figs. 1-4 ). No clear evidence indicated a time-related drift in the incidence rates. More recent data from the NTP also suggest that the tumour rate variability was little since 1980 (5) . Although factors affecting variability can be limited under strict conditions, it is often difficult in data collected from different sources, making the use of such historical control data of limited value. There are, however, occasions when the study results in the control groups make this option desirable. The use of historical control data in rodent bioassays has been discussed by several workers (2-4, 6). Occurrence of rare tumour types, presence of high-incidence tumours (pituitary adenomas in female rats), or tumour types with known variable incidence (pancreatic islet cell tumours in rats) are situations where historical control data could assist interpretation. The study control results falling near to the extremes of the range and marginally significant results on statistical analyses (border-line increase) are other instances where historical control data can prove valuable. The NTP has generated a large historical control data base for tumour rates from a number of different laboratories. Other organizations in Europe are also currently generating such data under carefully selected conditions. These include control animal pathology data prepared by the Centre for Medicines Research U.K. and the Registry of Industrial Toxicology Animal Data by the Fraunhofer Institute of Toxicology and Aerosal Research, Germany. When comparisons outside the study are considered, restrict their use to data arising from the laboratory where the study was carried out, use concurrent studies or those confined to a short window of time (k1-2 yr), and as far as possible include studies read by the same pathologist. The pathologist's factor could be improved by reviewing rllz evant data on specific tumour types from all studies by the same pathologist to avoid any drift in criteria. If one has to use historical control data, first define the data base, include only studies with identical design and conditions such as route of administration, duration of study, age at start of study, dietaiy and caging conditions, and source of animal supply. In addition, establish a rigourous review procedure for all pathology diagnoses using standardised nomenclature and diagnostic criteria and ascertain that uniform sampling techniques were followed in all studies prior to their inclusion into the data base. Identify the source of variability and exclude nonstandard studies. It is also of great importance to develop and utilize powerful statistical methods capable of handling multiple variables and survival patterns.
